Bio-Connect
WB analysis of HeLa cell lysates using GTX86891 Plasma Kallikrein 1B (cleaved Arg390) antibody. The lane on the right is blocked with the synthesized peptide.
WB analysis of HeLa cell lysates using GTX86891 Plasma Kallikrein 1B (cleaved Arg390) antibody. The lane on the right is blocked with the synthesized peptide.
WB analysis of HeLa cell lysates using GTX86891 Plasma Kallikrein 1B (cleaved Arg390) antibody. The lane on the right is blocked with the synthesized peptide.

Plasma Kallikrein 1B (cleaved Arg390) antibody

GTX86891
GeneTex
TargetKLKB1
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Plasma Kallikrein 1B (cleaved Arg390) antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    Plasma Kallikrein 1B (cleaved Arg390) antibody detects endogenous levels of fragment of activated KLKB1 resulting from cleavage adjacent to Arg390.
  • Application Supplier Note
    WB: 1:500~1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Formulation
    Liquid
  • Gene ID3818
  • Target name
    KLKB1
  • Target description
    kallikrein B1
  • Target synonyms
    kallikrein B, plasma (Fletcher factor) 1; kininogenin; KLK3; PKK; PKKD; plasma kallikrein; plasma prekallikrein; PPK
  • Protein IDP03952
  • Protein Name
    Plasma kallikrein
  • Scientific Description
    Plasma prekallikrein is a glycoprotein that participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation. It is synthesized in the liver and secreted into the blood as a single polypeptide chain. Plasma prekallikrein is converted to plasma kallikrein by factor XIIa by the cleavage of an internal Arg-Ile bond. Plasma kallikrein therefore is composed of a heavy chain and a light chain held together by a disulphide bond. The heavy chain originates from the amino-terminal end of the zymogen and contains 4 tandem repeats of 90 or 91 amino acids. Each repeat harbors a novel structure called the apple domain. The heavy chain is required for the surface-dependent pro-coagulant activity of plasma kallikrein. The light chain contains the active site or catalytic domain of the enzyme and is homologous to the trypsin family of serine proteases. Plasma prekallikrein deficiency causes a prolonged activated partial thromboplastin time in patients. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203